Etrasimod for ulcerative colitis

被引:0
|
作者
Baker, Holly
机构
来源
关键词
D O I
10.1053/j.gastro.2023.05.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:405 / 405
页数:1
相关论文
共 50 条
  • [1] Etrasimod for ulcerative colitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (08): : 708 - 708
  • [2] Etrasimod (Velsipity) for Ulcerative Colitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 187 - 189
  • [3] Etrasimod for the treatment of ulcerative colitis
    Wils, Pauline
    Peyrin-Biroulet, Laurent
    IMMUNOTHERAPY, 2023, 15 (05) : 311 - 321
  • [4] Ulcerative colitis Etrasimod approved from the Age of 16
    Warpakowski, Andrea
    VISCERAL MEDICINE, 2024, 40 (03)
  • [5] Etrasimod for ulcerative colitis: evaluating phase III results
    Matsuoka, Katsuyoshi
    Hibi, Toshifumi
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (12) : 762 - 763
  • [6] Hepatic Impact of Etrasimod for Treatment of Moderately to Severely Active Ulcerative Colitis: An Integrated Safety Summary From the Etrasimod Ulcerative Colitis Clinical Program
    Regueiro, Miguel
    Vermeire, Severine
    Rubin, David T.
    Dubinsky, Marla C.
    Hart, Ailsa
    Wu, Joseph
    Green, Jesse
    Woolcott, John C.
    Gorelick, Kenneth J.
    McDonnell, Aoibhinn
    Lazin, Krisztina
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S816 - S817
  • [7] Etrasimod for ulcerative colitis: evaluating phase III results
    Katsuyoshi Matsuoka
    Toshifumi Hibi
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 762 - 763
  • [8] Impact of Etrasimod on Blood Pressure and Hypertension: Data From the Etrasimod Ulcerative Colitis Clinical Program
    Vermeire, Severine
    Rubin, David T.
    Peyrin-Biroulet, Laurent
    Dubinsky, Marla C.
    Regueiro, Miguel
    Irving, Peter M.
    Goetsch, Martina
    Lazin, Krisztina
    Wu, Joseph
    Modesto, Irene
    Woolcott, John C.
    McDonnell, Aoibhinn
    Rabbat, Christopher J.
    Yarur, Andres J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S675 - S675
  • [9] Statement on the Benefit Assessment of Etrasimod (ulcerative Colitis, ≥ 16 Years)
    Jansen, Petra Lynen
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (10): : 1857 - 1861
  • [10] The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitis
    Atreya, Raja
    Neurath, Markus F.
    LANCET, 2023, 401 (10383): : 1132 - 1133